Indometacin Atb

Indometacin, the active ingredient in Indometacin Atb, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a suppository for rectal use. It is employed to relieve inflammation and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout attacks, post‑operative pain, and other acute musculoskeletal conditions.

GNH USA supplies Indometacin Atb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Indometacin Atb is an NSAID indicated for inflammatory and painful musculoskeletal disorders.

- Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Ankylosing spondylitis: diminishes spinal inflammation and associated pain. - Acute gout attacks: provides rapid relief of gout‑related joint swelling and tenderness. - Post‑operative pain: controls surgical site inflammation and postoperative discomfort.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dyspepsia: stomach discomfort or indigestion. - Nausea: feeling of sickness or urge to vomit. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness. - Diarrhea: loose, frequent stools.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or sudden loss of kidney function. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity: elevated liver enzymes or liver injury. - Cardiovascular events including myocardial infarction or stroke.

Before using Indometacin Atb, consider the following safety measures. - Gastrointestinal risk: avoid in patients with active ulcer disease or a history of GI bleeding. - Renal function: monitor kidney function in patients with pre‑existing renal impairment. - Cardiovascular health: use cautiously in individuals with hypertension or known cardiovascular disease. - Concomitant drugs: review all current medications for potential interactions. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Indometacin can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - High‑dose aspirin: additive renal and gastric adverse effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in dehydrated patients. - Diuretics: potential for reduced effectiveness and electrolyte imbalance. - Lithium: NSAIDs can raise lithium levels, risking toxicity. - Methotrexate: may increase methotrexate toxicity due to reduced renal clearance.